Tonsillitis Treatments

Find Tonsillitis Treatments

Brand Name

Cefixime

View Brand Information
FDA approval date: April 14, 2015
Classification: Cephalosporin Antibacterial
Form: Tablet, Powder, Capsule

What is Cefixime?

Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections.
Save this treatment for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances

Related Clinical Trials

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

Summary: Cephalosporin antibiotics are commonly used but can result in allergic reactions and anaphylaxis. There is no clear diagnostic approach for cephalosporin-allergic patients, and guidance for the use of other antibiotics in allergic patients is based on side chain chemical similarity and limited skin testing evidence. This project includes a clinical trial and mechanistic studies to optimize the app...

3-day Intravenous Antibiotic Treatment Versus 3-day Intravenous Followed by 7-day Oral Antibiotic Treatment for Acute Pyelonephritis in Children 1 Month to 3 Years Old: a Non-inferiority Open Randomized Multicentric Clinical Trial

Summary: Antibiotic therapies currently recommended for the treatment of acute pyelonephritis (AP) in children, whether fully by the oral route or initially intravenous (IV, 3 days) followed by the oral route, have a duration of 7 to 14 days (10 days in France). In children with no prior urological malformation, the global clinical and microbiological cure rate after antibiotic treatment completion is arou...

WHO-recommended Periodic Presumptive Treatment Versus Doxycycline Post-Exposure Prophylaxis for STI Control Among Cisgender Men Who Have Sex With Men in Kenya

Summary: Men who have sex with men (MSM) are at high risk for gonorrhea and chlamydia in Kenya, where nucleic acid amplification testing is not feasible and most infections therefore go undiagnosed. We propose an open-label randomized clinical trial with 2900 participants assigned to WHO-recommended periodic presumptive treatment (PPT) or doxycycline post-exposure prophylaxis (doxyPEP), compared to standar...

Brand Information

CEFIXIME (CEFIXIME)
1DOSAGE FORMS AND STRENGTHS
Cefixime Capsules are available for oral administration in the following dosage strength:
  • Capsules provide 400 mg of cefixime as trihydrate. These are off white to yellow colour granular powder filled in size  ''0''' hard gelatin capsules, pink opaque cap imprinted ''CFX'' with black ink and pink opaque body imprinted ''400'' with black ink.
2CONTRAINDICATIONS
Cefixime capsules are contraindicated in patients with known allergy to cefixime or other cephalosporins.
3OVERDOSAGE
Gastric lavage may be indicated; otherwise, no specific antidote exists. Cefixime is not removed in significant quantities from the circulation by hemodialysis or peritoneal dialysis. Adverse reactions in small numbers of healthy adult volunteers receiving single doses up to 2 g of cefixime did not differ from the profile seen in patients treated at the recommended doses.
4DESCRIPTION
Cefixime is a semisynthetic, cephalosporin antibacterial for oral administration. Chemically, it is (
Molecular weight = 507.50 as the trihydrate. Chemical Formula is C
The structural formula for cefixime is:
  • I nactive ingredients contained in cefixime capsules 400 mg are: colloidal silicon dioxide, croscarmellose sodium, low substituted hydroxypropyl cellulose, magnesium stearate and mannitol. The capsule shell contains the following inactive ingredients: black iron oxide, butyl alcohol, dehydrated alcohol, gelatin, iron oxide red, isopropyl alcohol, potassium hydroxide, propylene glycol, shellac, sodium lauryl sulphate, strong ammonia solution and titanium dioxide.
5HOW SUPPLIED/STORAGE AND HANDLING
Cefixime Capsules 400 mg
Off white to yellow color granular powder filled in size “0” hard gelatin capsules, pink opaque cap imprinted “CFX” with black ink and pink opaque body imprinted “400” with black ink.
NDC: 70518-2749-00
NDC: 70518-2749-01
NDC: 70518-2749-02
NDC: 70518-2749-03
NDC: 70518-2749-04
NDC: 70518-2749-05
PACKAGING: 10 in 1 BOTTLE PLASTIC
PACKAGING: 1 in 1 BOTTLE PLASTIC
PACKAGING: 2 in 1 BOTTLE PLASTIC
PACKAGING: 2 in 1 BLISTER PACK
PACKAGING: 2 in 1 BOX
PACKAGING: 1 in 1 POUCH
Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature
Repackaged and Distributed By:
Remedy Repack, Inc.
625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762